<DOC>
	<DOCNO>NCT01520064</DOCNO>
	<brief_summary>- Obtain analyze medical record data patient advance emphysema receive treatment AeriSeal System well understand safety effectiveness post-market setting ; - Provide participate physician access specify data set purpose generate scientific manuscript effect AeriSeal System treatment .</brief_summary>
	<brief_title>Post Market Registry Study AeriSeal System</brief_title>
	<detailed_description />
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Advanced Emphysema AeriSeal System treatment primary diagnosis asthma , chronic bronchitis bronchiectasis frequent COPD exacerbation within past year require mechanical ventilatory support pretreatment DLCO &lt; 20 % predict &gt; 60 % predict pretreatment FEV1 &lt; 20 % predict AND homogeneous emphysema giant bulla undergone lung transplantation , lung volume reduction surgery , lobectomy intolerant corticosteroid antibiotic pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Emphysema</keyword>
	<keyword>GOLD Stage III</keyword>
	<keyword>GOLD Stage IV</keyword>
	<keyword>AeriSeal System</keyword>
	<keyword>Homogeneous</keyword>
	<keyword>Heterogeneous</keyword>
	<keyword>Upper Lobe Predominant</keyword>
	<keyword>ULP</keyword>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>COPD</keyword>
	<keyword>Lung Volume Reduction Surgery</keyword>
	<keyword>LVRS</keyword>
	<keyword>Bronchoscopic Lung Volume Reduction</keyword>
	<keyword>BLVR</keyword>
</DOC>